Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
暂无分享,去创建一个
C. Perou | P. Bernard | K. Weber | A. Ruíz | A. Prat | E. Carrasco | L. Calvo | M. Casas | Á. Rodríguez-Lescure | M. Ruíz-Borrego | I. Álvarez | R. Caballero | Miguel Martín | R. Kronenwett | J. C. Brase | C. Rodríguez | C. Petry | M. Ruiz-Borrego | M. Seguí